These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30979310)

  • 1. Functionalized Polymers for Enhance Oral Bioavailability of Sensitive Molecules.
    Pérez YA; Urista CM; Martínez JI; Nava MDCD; Rodríguez FAR
    Polymers (Basel); 2016 Jun; 8(6):. PubMed ID: 30979310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Functionalized Polymeric Nanoparticles to Improve Intestinal Permeability of Drugs and Biological Products.
    de Souza ML; de Albuquerque Wanderley Sales V; Alves LP; Dos Santos WM; de Moura Ferraz LR; de Andrade Lima GS; Dos Santos Mendes LM; Rolim LA; Neto PJR
    Curr Pharm Des; 2022; 28(5):410-426. PubMed ID: 34348618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein and Peptide drug delivery: oral approaches.
    Shaji J; Patole V
    Indian J Pharm Sci; 2008; 70(3):269-77. PubMed ID: 20046732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in advanced oral drug delivery system for curcumin: A systematic review.
    Pan-On S; Dilokthornsakul P; Tiyaboonchai W
    J Control Release; 2022 Aug; 348():335-345. PubMed ID: 35654170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.
    Van den Bergh A; Van Hemelryck S; Bevernage J; Van Peer A; Brewster M; Mackie C; Mannaert E
    Mol Pharm; 2018 Jul; 15(7):2633-2645. PubMed ID: 29799758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.
    Paudwal G; Rawat N; Gupta R; Baldi A; Singh G; Gupta PN
    Curr Pharm Des; 2019; 25(13):1524-1535. PubMed ID: 31258070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion.
    Zhang S; Xu X; Sun W; Zhang Z; Pan B; Hu Q
    Eur J Pharm Sci; 2022 Jan; 168():106074. PubMed ID: 34798261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Sensitive Polymer-Based Carriers as a Useful Approach for Oral Delivery of Therapeutic Protein: A Review.
    Lori MS; Ohadi M; Estabragh MAR; Afsharipour S; Banat IM; Dehghannoudeh G
    Protein Pept Lett; 2021; 28(11):1230-1237. PubMed ID: 34303327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising strategies for improving oral bioavailability of poor water-soluble drugs.
    Rocha B; de Morais LA; Viana MC; Carneiro G
    Expert Opin Drug Discov; 2023 Jun; 18(6):615-627. PubMed ID: 37157841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
    Wang XQ; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging trends in oral delivery of peptide and protein drugs.
    Mahato RI; Narang AS; Thoma L; Miller DD
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability enhancement strategies: basics, formulation approaches and regulatory considerations.
    Beg S; Swain S; Rizwan M; Irfanuddin M; Malini DS
    Curr Drug Deliv; 2011 Nov; 8(6):691-702. PubMed ID: 21864253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes.
    Babadi D; Dadashzadeh S; Osouli M; Daryabari MS; Haeri A
    J Control Release; 2020 May; 321():669-709. PubMed ID: 32112856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocomposite systems for precise oral delivery of drugs and biologics.
    Andretto V; Rosso A; Briançon S; Lollo G
    Drug Deliv Transl Res; 2021 Apr; 11(2):445-470. PubMed ID: 33534107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the study of polymeric micelles used in oral administration].
    Chen D; Ding PT; Deng YH; Wang SL
    Yao Xue Xue Bao; 2010 May; 45(5):560-4. PubMed ID: 20931755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability.
    Parikh A; Kathawala K; Song Y; Zhou XF; Garg S
    Drug Deliv Transl Res; 2018 Oct; 8(5):1389-1405. PubMed ID: 29845380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.